KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $155,000 | +89.0% | 5,069 | +0.8% | 0.01% | +100.0% |
| Q2 2020 | $82,000 | +1950.0% | 5,029 | +1126.6% | 0.01% | – |
| Q1 2020 | $4,000 | -89.2% | 410 | -84.7% | 0.00% | -100.0% |
| Q4 2019 | $37,000 | -19.6% | 2,687 | -10.6% | 0.00% | -33.3% |
| Q3 2019 | $46,000 | +21.1% | 3,007 | +55.5% | 0.00% | 0.0% |
| Q2 2019 | $38,000 | +216.7% | 1,934 | +164.9% | 0.00% | +200.0% |
| Q1 2019 | $12,000 | -33.3% | 730 | -41.4% | 0.00% | -50.0% |
| Q4 2018 | $18,000 | -21.7% | 1,245 | -7.0% | 0.00% | 0.0% |
| Q3 2018 | $23,000 | -99.4% | 1,339 | +508.6% | 0.00% | – |
| Q2 2018 | $4,004,000 | +33266.7% | 220 | -68.2% | 0.00% | -100.0% |
| Q1 2018 | $12,000 | +500.0% | 691 | +785.9% | 0.00% | – |
| Q4 2017 | $2,000 | -33.3% | 78 | -65.3% | 0.00% | – |
| Q3 2017 | $3,000 | – | 225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |